1. Describe the current standard multidisciplinary treatment strategies for ductal carcinoma in situ (DCIS) of the breast
2. Identify the potential benefits of utilizing neoadjuvant systemic therapy for invasive breast cancer
3. Discuss the new surgical procedure called targeted axillary dissection and when it might be indicated

Accreditation Statement

In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Indiana University School of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

References:

For questions about accessibility or to request accommodations please contact the CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

To view any relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity, please click the names below.